77 results on '"Legrand, F."'
Search Results
2. 21P Mass cytometry reveals a population of exhausted CD8+ T cells associated with durvalumab/tremelimumab/vinorelbine efficacy in advanced cervical cancer (iMOVIE)
3. Hydration and clinical warning signs of Dengue fever in primary care: an observational prospective study
4. Étude M-HEMORRH’AGE : exposition médicamenteuse des patients âgés atteints d’hémophilie ou de maladie de Willebrand
5. MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors
6. 478P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Results of the tumor mutational burden-high (TMB-h) and/or microsatellite instability-high (MSI-h) cohort of the MOVIE study
7. Différencier la COVID-19 et la dengue des autres maladies fébriles dans un contexte de co-épidémie : développement et validation internes des scores COVIDENGUE
8. 775P Tremelimumab (T) + durvalumab (D) combined with metronomic oral vinorelbine (MOV): Results of the recurrent cervical cancer (RCC) cohort of the MOVIE study
9. 715P Nivolumab in pretreated metastatic penile squamous cell carcinoma: Results of the penile cohort from the French AcSé prospective program
10. Human dendritic cell maturation induced by synthetic amorphous silica nanoparticles is modulated by pulmonary surfactant
11. 274P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Efficacy and safety results of the advanced breast cancer (ABC) patients (pts) cohort of the MOVIE study
12. Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial
13. Foot ischemia related to essential thrombocytemia and atherosclerosis
14. Preliminary study on the effect of sex on skin cooling response during whole body cryostimulation (−110 °C): Modeling and prediction of exposure durations
15. Analyse comparative des caractéristiques cliniques et épidémiologiques des patients infectés par le SARS-CoV-2 et par le virus de la dengue dans un centre hospitalo-universitaire ultramarin
16. 526O High activity of nivolumab in patients with pathogenic exonucleasic domain POLE (edPOLE) mutated Mismatch Repair proficient (MMRp) advanced tumours
17. 343P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Efficacy and safety preliminary results of the advanced breast cancer (ABC) patients (pts) cohort of the MOVIE study
18. 555P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D) in advanced solid tumours (AST): Dose finding results
19. 1619O High clinical benefit rates of single agent pembrolizumab in selected rare sarcoma histotypes: First results of the AcSé Pembrolizumab study
20. Evaluation of zeta potential of nanomaterials by electrophoretic light scattering: Fast field reversal versus Slow field reversal modes
21. Tests and developments of a long-pulse high-power 170 GHz absorbing matched load
22. Recent experiments with the European 1MW, 170GHz industrial CW and short-pulse gyrotrons for ITER
23. Innovative Hybrid Mass Damper for Dual-Loop Controller
24. Should whole body cryotherapy sessions be differentiated between women and men? A preliminary study on the role of the body thermal resistance
25. Vemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial
26. EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors
27. Infrared thermography for assessing skin temperature differences between Partial Body Cryotherapy and Whole Body Cryotherapy devices at −140 °C
28. Whole body cryotherapy in fibromyalgia patients: Effects on pain and functional mobility
29. Corrigendum to “Effect of whole body cryotherapy interventions on health-related quality of life in fibromyalgia patients: A randomized controlled trial” [Complement. Ther. Med. 36 (2018) 6–8]
30. Double J utereral stent, how long is too long? Results of a European multicentric study
31. EXPRESS study: A multicenter, prospective trial in progress exploring the association between low level of genomic alteration and exceptional and unexpected response to targeted therapies in patients with solid tumors
32. Effect of whole body cryotherapy interventions on health-related quality of life in fibromyalgia patients: A randomized controlled trial
33. Évaluation de la taille des calculs urinaires avant urétéroscopie souple : quelle mesure choisir ?
34. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008)
35. Apport de l’hypnose eriksonienne dans la baisse du niveau d’anxiété prénatale chez la femme primigeste : étude de cas
36. Évaluation de la charge lithiasique avant urétéroscopie flexible : quelle mesure choisir ?
37. Hyperactivité vésicale idiopathique : efficacité et tolérance des traitements pharmacologiques : revue de la littérature
38. Size of monodispersed nanomaterials evaluated by dynamic light scattering: Protocol validated for measurements of 60 and 203 nm diameter nanomaterials is now extended to 100 and 400 nm
39. IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)
40. Évaluation des effets indésirables des instillations endovésicales par BCG : implication potentielle de la souche utilisée ?
41. 126O A phase I study evaluating the safety, efficacy, pharmacokinetics and pharmacodynamics of AL3810 in advanced solid tumors
42. 3032A Activity and safety profile of lucitanib in patients with advanced thymic epithelial tumours
43. La mucite post-allogreffe de cellules souches hématopoïétiques : facteurs de risque, conséquences cliniques et prévention
44. Prolonged Anti-Tumor Activity of Lucitanib in Advanced Thyroid Cancer
45. Recent achievements on tests of series gyrotrons for W7-X and planned extension at the KIT gyrotron test facility
46. P-212 Therapeutic management of MDS patients relapsing after allo-SCT: A large-scale study on behalf of the SFGM-TC
47. P-121 BCL2L10 is associated with resistance to azacitidine (AZA) in MDS and AML, and is a possible target in resistant patients
48. Prophylaxie antifongique par posaconazole dans un service d’hématologie soins intensifs : suivi pharmacologique thérapeutique et limites en pratique clinique
49. Le variant lymphoïde de syndrome hyper-éosinophilique avec phénotype T aberrant CD3−CD4+ : étude rétrospective de 19 patients du réseau éosinophile, de l’hyper-éosinophilie isolée au lymphome T
50. Arrêt de l’imatinib dans la leucémie chronique à éosinophiles FIP1L1-PDGFRA en rémission moléculaire : résultats d’une étude rétrospective chez 11 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.